Abstract:The senescence of the immune system and the risk of cancer increase with aging. Age itself entails changes in the immune system, which are related to a decrease in thymic output of naïve lymphocytes, an accumulation of chronic antigenic load, notably chronic viral infections such as cytomegalovirus (CMV), and replicative senescence of lymphocytes. These changes could eventually contribute to cancer risk and affect the response to cancer treatment. However, several confounding factors make it difficult to draw a picture of causal relationships. Studies in diverse human populations could contribute to clarify these complex relationships. Here, we summarize the current knowledge about the senescence of the T cells, the relationship with CMV infection, cancer, and cancer treatment. We also review the results of a series of studies performed in Cuba whose population is characterized by the unusual combination of long life expectancy and high antigenic load, including high seroprevalence of CMV, typical of tropical countries. Although immunosenescence affects almost all components and functions of the immune response, its most salient feature is a decrease in numbers and proportions of naïve CD8<sup>+</sup> T lymphocytes and an accretion of terminally differentiated CD8<sup>+</sup> T lymphocytes. These features were confirmed by the Cuban studies, but interestingly a clear gender effect also appeared. Moreover, as aging is a global phenomenon, a fast increase in elderly with malignancies is expected; therefore, the evaluation of patient's immune status would support the decision of treating them with immunotherapy and predict the efficacy of such treatments, thereby improving benefits for the patients.

CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer

The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders

CD4 T Cells Acquire Cytotoxic Properties to Modulate Cellular Senescence and Aging

A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing

Hallmarks of the aging T‐cell system

Are immunosenescent T cells really senescent?

T-cell immunity against senescence: potential role and perspectives

Abstract 3921: The aged tumor microenvironment limits CD8+ T cell control of cancer

Senescent T cells: a potential biomarker and target for cancer therapy

Senescence‐associated β‐galactosidase reveals the abundance of senescent CD8+ T cells in aging humans

Heterogeneity and transcriptome changes of human CD8+ T cells across nine decades of life

The impact of aging and senescence on CD4 T cell differentiation

CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets

T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies

The role of senescent T cells in immunopathology

Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes

The aged tumor microenvironment limits T cell control of cancer

Immunosenescence: a key player in cancer development

T-cell Immunoglobulin and ITIM Domain Contributes to CD8+ T-cell Immunosenescence.

Aging of the immune system: Focus on inflammation and vaccination

CD28null T cells in aging and diseases: From biology to assessment and intervention